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+A: Abstract 
Introduction Depending on which classification system is used, 15–60% of stillbirths 
remain unexplained, despite undergoing recommended autopsy examination, with 
variable attribution of fetal growth restriction (FGR) as a cause of death. 
Distinguishing small-for-gestational age (SGA) from pathological FGR is a challenge 
at postmortem examination. This study uses data from a large, well-characterized 
series of intrauterine death autopsies to investigate the effects of secondary changes 
such as fetal maceration, intrauterine interval and postmortem interval on 
interpretation of body weight. 
Methods Autopsy findings from intrauterine death investigations (2005–2013 
inclusive, from Great Ormond Street Hospital and St George’s Hospitals, London), 
were collated into a research database. Growth charts published by the World Health 
Organization were used to determine normal expected weight centiles for fetuses born 
after 23 weeks’ gestation and the effects of intrauterine retention (maceration) and 
postmortem interval calculated. 
Results There were 1064 intrauterine deaths, including 533 stillbirths ≥ 24 weeks’ 
gestation) with a recorded birth weight. Of these, 192 (36%) had unadjusted birth 
weight below the 10th centile and were defined as SGA. The majority (86%) of 
stillborn SGA fetuses demonstrated some degree of maceration, indicating a 
significant period of intrauterine retention after death. A significantly greater 
proportion of macerated fetuses were present in the SGA population compared with 
the non-SGA population (P = 0.01). There was a significant relationship between 
increasing intrauterine retention interval (IUI) and both more severe maceration and 
reduction in birth weight (P < 0.0001 for both), with an average artefactual reduction 
in birth weight of around –0.8SD of expected weight. There was an average 12% 
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reduction in fetal weight between delivery and autopsy and, as postmortem interval 
(PMI) increased, fetal weight loss increased (P = 0.0001).  
Conclusion Based on birth weight alone, 36% of stillbirths are classified as SGA. 
However, fetuses lose weight in utero with increasing IUI and continue to lose weight 
between delivery and autopsy, resulting in erroneous overestimation of FGR.  
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+A: Introduction 
Depending on which classification system is used, between 15% and 60% of 
stillbirths remain unexplained, despite undergoing recommended autopsy 
examination1,2. Much of this difference is related to the variable attribution of fetal 
growth restriction (FGR) as a cause of death. FGR implies pathological restriction of 
growth potential, whereas small-for-gestational age (SGA) simply describes an infant 
whose biometry falls below an arbitrary centile, usually the 5th or 10th, of an expected 
normal range for gestational age3,4. Not all FGR fetuses are SGA and not all SGA 
fetuses are FGR; the likelihood of FGR increases with the magnitude of SGA, such 
that, for example, 30% of fetuses < 10th centile are estimated to be FGR, compared 
with 70% of foetuses < 3rd centile. Fetal birth weight is affected not aonly by 
pathological abnormalities but also by physiological differences, including parental 
ethnicity, height and parity3. Customized growth charts have been suggested to reduce 
such effects3,5. Despite this, distinguishing incidental SGA from pathological FGR is 
challenging, especially at postmortem examination following intrauterine death.   
FGR/SGA has been suggested as the single largest population-attributable risk 
for stillbirth, most studies being based on unadjusted weight at birth, with around 40% 
of stillborn infants being below the 10th birth weight centile for liveborn infants6. 
However, antenatal detection rates for fetuses delivered SGA are generally poor (15–
25%)7,8 and it has been suggested that increased surveillance for SGA may improve 
its detection and reduce stillbirth rates6,9. Despite these approaches, there are 
remarkably few published data attempting to quantify the possible effects on body 
weight of changes occurring following intrauterine death.   
This study, therefore, aimed to use data from a large, well-characterized series of 
autopsies following stillbirth death to investigate the frequency of SGA, and to 
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address the role that secondary changes such as fetal maceration, intrauterine interval 
and postmortem interval may have on the interpretation of birth weight. 
 
+A: Methods 
As part of a larger study examining autopsy findings in the investigation of 
intrauterine death, a dedicated Microsoft Access Autopsy Database (Microsoft Corp., 
Redmond, WA, USA) was used to collate detailed autopsy and antenatal details from 
intrauterine deaths examined between 2005 and 2013, inclusive, at Great Ormond 
Street Hospital and St George’s Hospitals, London. Every case was reviewed 
manually and data extracted according to strict, predefined, objective criteria, 
separating objective autopsy findings from pathologist interpretations. Data were then 
analyzed through queries and statistical tests using Microsoft Access and Microsoft 
Excel (Microsoft Corp.), GraphPad Prism (GraphPad Software Inc., San Diego, CA, 
USA) and Stats Direct (StatsDirect Ltd., Altrincham, UK) software packages. 
Statistical tests included chi-square, t-test and Mann–Whitney U-test and regression 
analysis, as appropriate. P < 0.05 was considered statistically significant.  
Neonatal growth charts published by the World Health Organization (WHO) 
were used to determine normal expected weight centiles for fetuses born ≥ 24 weeks’ 
gestation, with males and females being evaluated separately since infant sex has a 
marked effect on birth weight11. Customized growth charts were not used due to the 
relative lack of detailed maternal demographic information available from archival 
postmortem reports. Nevertheless, since all comparisons between groups were based 
on the same reference range dataset, all intergroup differences and trends remain 
valid. These normal range data were used to determine the gestational-age-corrected 
expected birth weights for each case, from which the birth-weight delta value was 
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calculated (defined as the number of SDs by which the observed birth weight differed 
from the expected (50th centile) birth weight from the normal range adjusted for fetal 
sex). Delta birth weights therefore allowed comparison between cases independent of 
fetal sex and gestational age. A negative delta birth-weight value indicated that the 
observed weight was less than expected based on the normal (livebirth) ranges. For 
the purposes of this study, cases with a delta value below –1.375, representing the 10th 
centile of the normal range, were denoted as SGA. Gestational age was calculated 
based on clinical and sonographic information provided.  
 
+A: Results 
Among a total of 1064 intrauterine death autopsies, there were 533 stillbirths with a 
recorded birth weight delivered at ≥ 24 weeks of gestation, which comprise the 
dataset for this study. Of these, 192 (36%) had unadjusted birth weight < 10th centile 
and were thus classified as SGA based on the WHO11 charts for normal livebirths 
(38% of male infants and 34% of female infants; z = 0.94, P = 0.35). Around half 
(47%) of the cases of SGA had no other specific identifiable cause of death at 
autopsy, whilst the most common specific category of death was placental 
abnormality (19%), typical of pathological FGR and maternovascular malperfusion12 
(Figure 1). Ninety of the 335 (27%) cases of stillbirth with an otherwise unexplained 
cause of death and no pathological findings at autopsy were SGA.  
The majority of mothers had a normal BMI but the SGA group had a higher 
proportion of underweight mothers than did the non-SGA group SGA (z = 2.29, 
P = 0.02). Twenty-four (12.5%) of SGA fetuses had mothers with some form of 
hypertension, of whom 42% had pre-eclampsia.  
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The majority (86%) of SGA stillborn fetuses had some degree of maceration 
noted at autopsy, indicating a significant period of intrauterine retention following 
intrauterine death; 76% of non-SGA stillborn fetuses showed maceration (z=2.74, 
P=0.01). Of the overall 424 cases with maceration present in whom grading was 
possible, 28 (7%) were SGA with mild maceration and 100 (24%) were SGA with 
moderate or severe maceration. A significantly greater proportion of macerated 
fetuses were present in the SGA population compared with the non-SGA population 
(z = 2.57, P = 0.01). Since cases of ascending infection are more likely to be fresh 
stillbirths and hence non-macerated, analysis was performed with these cases 
excluded, but the significantly greater proportion of maceration in the SGA 
population persisted (z = 2.02, P = 0.04), indicating that maceration itself is 
associated with reduced body weight for gestational age. 
To explore this relationship further, the intrauterine retention interval (IUI) 
was calculated, as the minimum time that the fetus had been dead in utero before 
delivery, according to either serial ultrasound scan findings or clinical history; 
intrapartum deaths were recorded as having 0 days of IUI. There were 308 cases of 
stillbirth ≥ 24 weeks of gestation with recorded birth weight, bodyweight at autopsy 
and well-documented IUI. They demonstrated a significant relationship between 
increasing IUI and increasing severity of maceration (z = 15.45, P < 0.0001). 
However, severity of maceration was not related closely to exact IUI; there was 
moderate or severe maceration in all cases with prolonged (> 4 days) IUI, along with 
some cases with IUI of only 2 days. Presence of significant maceration therefore 
appears to be a reliable indicator that an intrauterine death occurred > 48 h prior to 
delivery, but cannot be used further to determine reliably the period since death and 
delivery. 
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Based on the 308 cases delivering ≥ 24 weeks with known IUI in whom delta 
birth weight could be calculated, there was a significant linear relationship between 
IUI and delta birth weight (P < 0.0001; Figure 2); as IUI increased, delta birth weight 
decreased, indicating that, with increasing IUI, fetuses lose increasing body weight in 
utero. Following an average interval between intrauterine death and delivery of 
around 3–4 days in this study, there was an artefactual reduction in birth weight of 
around –0.8SDs of expected weight. The proportion of SGA cases defined as 
birthweight <10th centile in stillbirths ≥ 24 weeks was 21% for those with 0 days IUI, 
30% for those with 1–2 days IUI and 45% for those with > 2 days IUI. There were 
significantly more fetuses with an IUI > 2 days in the SGA group (z = 3.01, 
P = 0.003; Figure 3). 
Finally, among the overall 1064 intrauterine deaths with autopsy results, there 
were 615 cases across all gestational ages with reliably recorded birth weight and 
bodyweight at autopsy, and these were used to calculate the percentage fetal weight 
change during the period between birth and autopsy (postmortem interval (PMI)). 
There was an average 12% reduction in fetal weight during the period of fetal 
refrigeration pending autopsy, with a median PMI of 7 days. As PMI increased, the 
proportion of fetal weight loss increased (P = 0.0001; Figure 4). Using body weight at 
autopsy rather than birth weight resulted in a 12% increase in the proportion of cases 
classified as SGA.   
 
+A: Discussion 
We found that, based on unadjusted birth weight using standard infant weight 
charts11, 36% of stillbirths ≥ 24 weeks of gestation are classified as SGA. However, 
this large dataset allowed investigation of factors which occur following intrauterine 
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death, demonstrating that, following intrauterine death, fetuses lose weight in utero in 
relation to increasing IUI as the process of maceration occurs, such that after a delay 
between death and delivery of 3–4 days, there has been an artefactual reduction in 
birthweight of around –0.8SDs. Furthermore, fetuses continue to lose weight, even 
when refrigerated, between delivery and autopsy; by 7 days post-delivery there has 
been an additional 12% loss of bodyweight. These data indicate that, using unadjusted 
birth weight (and even more so using autopsy bodyweight), there is erroneous 
overestimation of the proportion of fetuses which are SGA, due to changes that occur 
after death, and the likely true proportion of pathological FGR with SGA in stillborn 
infants is likely to be around 20–25% rather than 35–40%.  
 Few previous studies have attempted to address this issue in a systematic or 
quantitative manner, although practising pathologists are well aware that maceration 
after death can result in significant changes in fetal appearance. It is established that 
stillborn birth weights are lower compared with gestational-age-matched livebirths, as 
evidenced by ‘normal range’ data provided in standard perinatal pathology texts13,14. 
However, only by using large well-defined datasets can temporal relationships 
between changes in bodyweight after death and intrauterine retention be examined. A 
previous study compared macerated with non-macerated fetuses and reported that 
organ weights of liver, thymus, and spleen decreased markedly with increasing 
maceration, consistent with the current data15.  There is one previous study of fetal 
weight changes between delivery and autopsy, including 212 cases, which reported an 
average 7% decrease in fetal bodyweight from birth to autopsy (with a shorter average 
PMI than our present study), consistent with current data and further highlighting 
discordancy between birth and postmortem body weights16.  
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 Whilst those with experience of delivering a fetus which has been retained in 
utero for some time are aware that many changes occur following death, with 
shrinkage in fetal mass associated with maceration, this is the first study to provide 
quantitative data regarding the extent of this effect, and demonstrates that significant 
changes occur within a few days of death. The mechanisms of such changes of 
intrauterine maceration in humans are uncertain, and are difficult to study directly. 
Early weight changes are likely to be due to shifts in fluid distribution in association 
with loss of normal homeostasis, with cellular autolysis and enzymatic degradation 
particularly affecting metabolically and hormonally active organs such as liver and 
pancreas. This is supported by data derived from the food industry indicating ongoing 
metabolic alterations for several hours after death followed by marked changes in 
tissue proteome profiles by 48 h17,18. Evidence of ongoing change is provided by the 
finding that the degree of maceration increases with IUI19. 
 This is the largest dataset available presenting detailed and granular stillbirth 
autopsy data. Furthermore, the dataset is unique in that variables were collected and 
recorded into a dedicated research database according to objective and predefined 
criteria and cases classified objectively according to autopsy and clinical findings to 
ensure consistency. Nevertheless, this remains a retrospective dataset, an issue which 
is intrinsic to all studies of stillbirth, since this represents a rare event and hence is 
generally unsuitable for prospective studies to address reasonably. However, the large 
size and objective criteria of the current dataset allow analyses to be performed which 
have not been possible previously and provide the best available evidence for changes 
after death in stillbirth.  
                These data support the concept that impaired fetal growth likely contributes 
to stillbirth; even using adjusted estimates, it confirms that the proportion of SGA in 
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stillbirths is greater than expected in an unselected population. Nevertheless, the 
contribution of FGR to otherwise clinically unexpected third-trimester stillbirth is 
likely to be less than suggested previously based on unadjusted birth weight or 
autopsy weights, since changes during in-utero retention and following delivery had 
not been taken into account. Current studies to improve detection of FGR are likely to 
have an important effect on reducing stillbirth rates, but the magnitude of reduction 
may be less than initially hoped20. Our findings, therefore, have potential implications 
for programmes to increase the detection of FGR and reduce stillbirth rates. To 
further assess the relationship between stillbirth and FGR, ongoing research is 
required into the biological and pathological mechanisms of death in FGR, and must 
also account for postmortem changes. It is essential that birth weight is measured as 
soon after delivery as is practical, and that a detailed clinical history is obtained to 
estimate more accurately the duration of in-utero retention in all stillbirths. 
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Figure 1 Cause of death in 533 stillbirths with a recorded birth weight, according to 
whether they were small-for-gestational age (SGA, □) or non-SGA (□). Congenital 
abnormalities and placental causes of death were more frequent in SGA cases 
(z = 2.8, P = 0.005 and z = 6.04, P < 0.0001, respectively); unexplained deaths were 
more frequent in non-SGA cases (z =  5.58, P < 0.0001). 
  
0
10
20
30
40
50
60
70
80
P
e
rc
e
n
ta
g
e
 o
f 
ca
se
s
Cause of death
% Non SGA
% SGA
16 
 
 
 
 
Figure 2 Relationship between interval from intrauterine death to delivery (IUI) and 
adjusted birthweight in 308 stillbirths >24 weeks’ for whom well-documented IUI 
were provided.  
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(Inset; only those cases with IUI < 12 days (N=296). There was a significant linear 
relationship between increasing IUI and reducing delta birth weight (P < 0.0001); this 
relationship persisted even when only data with IUI < 12 days were evaluated.  
 
 
 
Figure 3 Interval between intrauterine death and delivery (IUI) in 533 stillbirths ≥ 24 
weeks with a recorded birth weight, according to whether they were small-for-
gestational age (SGA, □) or non-SGA (□). There were significantly more fetuses with 
a prolonged IUI (> 2 days) in the SGA group (z = 3.01, P = 0.003) and the proportion 
of SGA cases increased with increasing IUI. 
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Figure 4 Relationship between average percentage weight loss and postmortem 
interval (PMI) in 533 stillbirths ≥ 24 weeks with a recorded birth weight; as PMI 
increased, percentage weight loss increased (P < 0.001). 
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